RTW Investments’s Avita Medical RCEL Stock Holding History

RTW Investments’s Portfolio RCEL Stock Details RCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-106,667	Closed	-$507K	–	98
2022 Q2	$507K	Hold	106,667	–	–	0.01%	102
2022 Q1	$905K	Hold	106,667	–	–	0.02%	98
2021 Q4	$1.28M	Sell	106,667 -173,333	-62%	-$2.64M	0.02%	116
2021 Q3	$4.96M	Hold	280,000	–	–	0.07%	95
2021 Q2	$5.75M	Hold	280,000	–	–	0.09%	87
2021 Q1	$5.55M	Buy	+280,000	New	+$6.51M	0.09%	89

Other funds holding RCEL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

RTW Investments's RCEL Position: Q3 2022 in Review

RTW Investments sold out of Avita Medical (RCEL) in Q3 2022, closing a stake of 106,667 shares — an estimated $507K sold.

RTW Investments first reported a position in RCEL in Q1 2021 and held it in 6 quarters. The position peaked at $5.75M in Q2 2021. 48 funds tracked by Wall St. Rank hold RCEL as of Q3 2022.

RTW Investments reported no remaining Avita Medical position as of Q3 2022 after selling out during the quarter.
RTW Investments sold 106,667 Avita Medical shares in Q3 2022, an estimated $507K.
RTW Investments first reported a position in Avita Medical in Q1 2021 and held it in 6 quarters.
RTW Investments's Avita Medical position peaked at $5.75M in Q2 2021.
48 funds tracked by Wall St. Rank held Avita Medical as of Q3 2022.

Based on RTW Investments's 13F filing for Q3 2022, filed 14 Nov 2022.